As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Anaesthesia Drugs Market: By Route of Administration: Inhalation, Injection, Others; By Drug Type: General Drug, Local Drug; By Application: General Surgery, Plastic Surgery, Others; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics; Competitive Landscape; Industry Events and Developments

Global Anaesthesia Drugs Market Outlook

The global anaesthesia drugs market stood at a value of nearly USD 5.91 billion in 2020. The market is further expected to grow at a CAGR of 3.4% in the forecast period of 2021-2026 to attain a value of almost USD 7.22 billion by 2026.

 

Growing Use of Local Drugs to Augment the Global Anaesthesia Drugs Industry

On the basis of drug type, the local drug segment accounted for a significant share in the market and is anticipated to witness a steady growth over the forecast period. The growth can be attributed to the rising demand for local drugs in various applications, particularly dental surgeries. The anticipated increase in minor procedures such as filling or wisdom tooth removal is expected to bolster the demand for local anaesthetics. Meanwhile, the growing awareness about the benefits of general drugs, which include reduced intraoperative patient awareness and complete control of the airway, breathing and circulation, among others, is expected to aid the growth of the segment.

Based on the route of administration, the inhalation segment is likely to account for a significant share in the market owing to the cost-effectiveness of the method and its precise control over the anaesthetic state. Also, the inhaled anaesthetics have a low solubility in the blood and tissues, possess a protective effect and are resistant to physical and metabolic degradation, thus, further contributing to the demand growth.

 

Anaesthesia Drugs Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

North America Accounts for a Significant Share in the Global Anaesthesia Drugs Industry

North America, due to rapid technological advancements and the high healthcare expenditure, accounts for a considerable share in the market. The region is further expected to be aided by the increasing number of surgeries in countries like the United States and Canada. Meanwhile, Europe and the Asia Pacific are likely to grow at a significant rate in the forecast period owing to the ongoing healthcare reforms in the regions. The increasing focus to improve access to healthcare facilities in emerging countries of the Asia Pacific is expected to significantly contribute to the market growth in the forecast period.

 

Anaesthesia Drugs: Industry Definition and Segmentation

Anaesthesia can be defined as the use of medicines to prevent pain during a medical procedure. Thus, the combination of medications that put a person in a sleep-like state before a surgery or some other medical procedure is known as anaesthetic drug. Anaesthetic drugs are used to ensure that a patient is in a completely unconscious state so that he/she does not feel any kind of pain.

Based on route of administration, the market is divided into:

  • Inhalation
  • Injection
  • Others

On the basis of drug type, the industry is segmented into:

  • General Drug
  • Local Drug

While the general drug segment is further divided into propofol, sevoflurane, desflurane, dexmedetomidine, remifentanil, midazolam, and others, the local drug segment is further categorised into bupivacaine, ropivacaine, lidocaine, chloroprocaine, prilocaine, benzocaine, and others.

The significant applications of the product are:

  • General Surgery
  • Plastic Surgery
  • Cosmetic Surgery
  • Dental Surgery
  • Others

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Increasing Prevalence of Gastrointestinal Diseases to Boost the Growth of the Anaesthesia Drugs Industry

The global anaesthesia drugs industry is driven by the rising prevalence of gastrointestinal diseases, such as gastroesophageal disease, liver cirrhosis, pancreatitis, and inflammatory bowel disease, among others. These diseases require intense surgery to attack the root of the disease, therefore, appropriate anaesthesia is needed for the safety of the patients. In addition, the easy availability of local drugs and the increasing hospitalisation rates are significantly contributing to the market growth. Over the forecast period, the market is expected to be aided by the rapid advancements in the healthcare industry.

 

Key Industry Players in the Global Anaesthesia Drugs Market

The report gives a detailed analysis of the following key players in the global anaesthesia drugs market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Pfizer Inc.
  • Fresenius SE & Co. KGaA
  • Baxter International, Inc.
  • AbbVie Inc.
  • B. Braun Melsungen AG
  • Piramal Enterprises Limited
  • Others

The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model along with giving a SWOT analysis.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2016-2020
Forecast Period 2021-2026
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Route of Administration, Drug Type, Application, Regions
Breakup by Route of Administration Inhalation, Injection, Others
Breakup by Drug Type General Drug, Local Drug
Breakup by Application General Surgery, Plastic Surgery, Cosmetic Surgery, Dental Surgery, Others
Breakup by Regions North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles-Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Pfizer Inc., Fresenius SE & Co. KGaA, Baxter International, Inc., AbbVie Inc., B. Braun Melsungen AG, Piramal Enterprises Limited, Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Anaesthesia Drugs Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Anaesthesia Drugs Historical Market (2016-2020) 
    8.3    Global Anaesthesia Drugs Market Forecast (2021-2026)
    8.4    Global Anaesthesia Drugs Market by Route of Administration
        8.4.1    Inhalation
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2016-2020)
            8.4.1.3    Forecast Trend (2021-2026)
        8.4.2    Injection
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2016-2020)
            8.4.2.3    Forecast Trend (2021-2026)
        8.4.3    Others
    8.5    Global Anaesthesia Drugs Market by Drug Type
        8.5.1    General Drug
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2016-2020)
            8.5.1.3    Forecast Trend (2021-2026)
            8.5.1.4    Breakup by Type
                8.5.1.4.1    Propofol
                8.5.1.4.2    Sevoflurane
                8.5.1.4.3    Desflurane
                8.5.1.4.4    Dexmedetomidine
                8.5.1.4.5    Remifentanil
                8.5.1.4.6    Midazolam
                8.5.1.4.7    Others
        8.5.2    Local Drug
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2016-2020)
            8.5.2.3    Forecast Trend (2021-2026)
            8.5.2.4    Breakup by Type
                8.5.2.4.1    Bupivacaine
                8.5.2.4.2    Ropivacaine
                8.5.2.4.3    Lidocaine
                8.5.2.4.4    Chloroprocaine
                8.5.2.4.5    Prilocaine
                8.5.2.4.6    Benzocaine
                8.5.2.4.7    Others
    8.6    Global Anaesthesia Drugs Market by Application
        8.6.1    General Surgery
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2016-2020)
            8.6.1.3    Forecast Trend (2021-2026)
        8.6.2    Plastic Surgery
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2016-2020)
            8.6.2.3    Forecast Trend (2021-2026)
        8.6.3    Cosmetic Surgery
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2016-2020)
            8.6.3.3    Forecast Trend (2021-2026)
        8.6.4    Dental Surgery
            8.6.4.1    Market Share
            8.6.4.2    Historical Trend (2016-2020)
            8.6.4.3    Forecast Trend (2021-2026)
        8.6.5    Others
    8.7    Global Anaesthesia Drugs Market by Region
        8.7.1    Market Share
            8.7.1.1    North America
            8.7.1.2    Europe
            8.7.1.3    Asia Pacific
            8.7.1.4    Latin America
            8.7.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2016-2020)
        9.1.2    Forecast Trend (2021-2026)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2016-2020)
        9.2.2    Forecast Trend (2021-2026)
        9.2.3    Breakup by Country 
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2016-2020)
        9.3.2    Forecast Trend (2021-2026)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2016-2020)
        9.4.2    Forecast Trend (2021-2026)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2016-2020)
        9.5.2    Forecast Trend (2021-2026)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    Pfizer Inc.
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    Fresenius SE & Co. KGaA
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3    Baxter International, Inc.
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    AbbVie Inc.
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    B. Braun Melsungen AG
            12.2.5.1    Company Overview
            12.2.5.2    Product Portfolio
            12.2.5.3    Demographic Reach and Achievements
            12.2.5.4    Certifications
        12.2.6    Piramal Enterprises Limited
            12.2.6.1    Company Overview
            12.2.6.2    Product Portfolio
            12.2.6.3    Demographic Reach and Achievements
            12.2.6.4    Certifications
        12.2.7    Others
13    Industry Events and Developments


List of Figures and Tables

1.    Global Anaesthesia Drugs Market: Key Industry Highlights, 2016 and 2026
2.    Global Anaesthesia Drugs Historical Market: Breakup by Route of Administration (USD Billion), 2016-2020
3.    Global Anaesthesia Drugs Market Forecast: Breakup by Route of Administration (USD Billion), 2021-2026
4.    Global Anaesthesia Drugs Historical Market: Breakup by Drug Type (USD Billion), 2016-2020
5.    Global Anaesthesia Drugs Market Forecast: Breakup by Drug Type (USD Billion), 2021-2026
6.    Global Anaesthesia Drugs Historical Market: Breakup by Application (USD Billion), 2016-2020
7.    Global Anaesthesia Drugs Market Forecast: Breakup by Application (USD Billion), 2021-2026
8.    Global Anaesthesia Drugs Historical Market: Breakup by Region (USD Billion), 2016-2020
9.    Global Anaesthesia Drugs Market Forecast: Breakup by Region (USD Billion), 2021-2026
10.    North America Anaesthesia Drugs Historical Market: Breakup by Country (USD Billion), 2016-2020
11.    North America Anaesthesia Drugs Market Forecast: Breakup by Country (USD Billion), 2021-2026
12.    Europe Anaesthesia Drugs Historical Market: Breakup by Country (USD Billion), 2016-2020
13.    Europe Anaesthesia Drugs Market Forecast: Breakup by Country (USD Billion), 2021-2026
14.    Asia Pacific Anaesthesia Drugs Historical Market: Breakup by Country (USD Billion), 2016-2020
15.    Asia Pacific Anaesthesia Drugs Market Forecast: Breakup by Country (USD Billion), 2021-2026
16.    Latin America Anaesthesia Drugs Historical Market: Breakup by Country (USD Billion), 2016-2020
17.    Latin America Anaesthesia Drugs Market Forecast: Breakup by Country (USD Billion), 2021-2026
18.    Middle East and Africa Anaesthesia Drugs Historical Market: Breakup by Country (USD Billion), 2016-2020
19.    Middle East and Africa Anaesthesia Drugs Market Forecast: Breakup by Country (USD Billion), 2021-2026
20.    Global Anaesthesia Drugs Market Structure

Key Questions Answered in the Report

In 2020, the global anaesthesia drugs market attained a volume of nearly USD 5.91 billion.

The market is estimated to grow at a CAGR of 3.4% in the forecast period of 2021-2026.

The market is estimated to witness a healthy growth in the forecast period of 2021-2026 to reach USD 7.22 billion by 2026.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

Inhalation, and injection, among others are the different routes of administration of the product.

General drug (propofol, sevoflurane, desflurane, dexmedetomidine, remifentanil, midazolam, and others) and local drug (bupivacaine, ropivacaine, lidocaine, chloroprocaine, prilocaine, benzocaine, and others) are the different drug types of the product.

General surgery, plastic surgery, cosmetic surgery, and dental surgery, among others are the significant applications of the product.

The major players in the industry are Pfizer Inc., Fresenius SE & Co. KGaA, Baxter International, Inc., AbbVie Inc., B. Braun Melsungen AG, and Piramal Enterprises Limited, among others.

Analyst Review

The global anaesthesia drugs market attained a value of almost USD 5.91 billion in 2020, driven by the growing prevalence of gastrointestinal diseases, growing use of local drugs, and improving healthcare industry. Aided by the rapid advancements in drug delivery methods and anaesthesiology techniques, the market is expected to witness a further growth in the forecast period of 2021-2026, growing at a CAGR of 3.4%. The market is projected to reach USD 7.22 billion by 2026.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on route of administration, the market is divided into inhalation and injection, among others. On the basis of drug type, the market is divided into general drug and local drug. Among these, while the general drug segment is further divided into propofol, sevoflurane, desflurane, dexmedetomidine, remifentanil, midazolam, and others, the local drug segment is further categorised into bupivacaine, ropivacaine, lidocaine, chloroprocaine, prilocaine, benzocaine, and others. The significant applications of the product include general surgery, plastic surgery, cosmetic surgery, and dental surgery, among others. The major regional markets for anaesthesia drugs are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Pfizer Inc., Fresenius SE & Co. KGaA, Baxter International, Inc., AbbVie Inc., B. Braun Melsungen AG, and Piramal Enterprises Limited, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER